Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report.

Comito F, Grassi E, Poerio A, Freier E, Calculli L, Zompatori M, Ricci C, Casadei R, Di Marco M.

BJR Case Rep. 2018 Feb 5;4(2):20170086. doi: 10.1259/bjrcr.20170086. eCollection 2018.

2.

Helminths of Wild Boar ( Sus scrofa) in the Calabrian Region of Southern Italy.

Castagna F, Musella V, Esposito L, Poerio A, Rinaldi L, Bosco A, Cringoli G, Britti D.

J Wildl Dis. 2018 Oct 12. doi: 10.7589/2018-02-028. [Epub ahead of print]

PMID:
30311535
3.

Comment on "Extracolonic Findings at Screening CT Colonography: Prevalence, Benefits, Challenges, and Opportunities".

Poerio A, Monteduro F, Zompatori M.

AJR Am J Roentgenol. 2017 Dec;209(6):W408. doi: 10.2214/AJR.17.18719. No abstract available.

PMID:
29161144
4.

Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques?

Gelsomino F, Fiorentino M, Zompatori M, Poerio A, Melotti B, Sperandi F, Gargiulo M, Borghi C, Ardizzoni A.

Ann Oncol. 2018 Jan 1;29(1):284-286. doi: 10.1093/annonc/mdx718. No abstract available.

PMID:
29106493
5.

Radiologic findings of Fusarium pneumonia in neutropenic patients.

Sassi C, Stanzani M, Lewis RE, Vianelli N, Tarsi A, Poerio A, Cavo M, Battista G.

Mycoses. 2017 Feb;60(2):73-78. doi: 10.1111/myc.12538. Epub 2016 Jul 29.

PMID:
27470138
6.

Incidental finding of bronchial diverticula in a non-smoker population: evaluation on thin-section CT.

Ciccarese F, Garzillo G, Chiesa AM, Poerio A, Baroncini S, Bacchi Reggiano ML, Sverzellati N, Zompatori M.

Monaldi Arch Chest Dis. 2016 Jun 22;81(1-2):743. doi: 10.4081/monaldi.2015.743.

7.

Effect of dietary supplementation on lipid photooxidation in beef meat, during storage under commercial retail conditions.

Cardenia V, Massimini M, Poerio A, Venturini MC, Rodriguez-Estrada MT, Vecchia P, Lercker G.

Meat Sci. 2015 Jul;105:126-35. doi: 10.1016/j.meatsci.2015.02.010. Epub 2015 Feb 28.

PMID:
25863872
8.

Saber-sheath trachea as a marker of severe airflow obstruction in chronic obstructive pulmonary disease.

Ciccarese F, Poerio A, Stagni S, Attinà D, Fasano L, Carbonara P, Bacchi Reggiani ML, Zompatori M.

Radiol Med. 2014 Feb;119(2):90-6. doi: 10.1007/s11547-013-0318-3. Epub 2013 Dec 3.

PMID:
24297576
9.

Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis.

Soverini S, Vitale A, Poerio A, Gnani A, Colarossi S, Iacobucci I, Cimino G, Elia L, Lonetti A, Vignetti M, Paolini S, Meloni G, di Maio V, Papayannidis C, Amabile M, Guarini A, Baccarani M, Martinelli G, Foà R.

Haematologica. 2011 Apr;96(4):552-7. doi: 10.3324/haematol.2010.034173. Epub 2010 Dec 29.

10.

IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis.

Soverini S, Score J, Iacobucci I, Poerio A, Lonetti A, Gnani A, Colarossi S, Ferrari A, Castagnetti F, Rosti G, Cervantes F, Hochhaus A, Delledonne M, Ferrarini A, Sazzini M, Luiselli D, Baccarani M, Cross NC, Martinelli G.

Leukemia. 2011 Jan;25(1):178-81. doi: 10.1038/leu.2010.236. Epub 2010 Oct 21. No abstract available.

PMID:
20962862
11.

The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase.

Palandri F, Castagnetti F, Iacobucci I, Martinelli G, Amabile M, Gugliotta G, Poerio A, Testoni N, Breccia M, Bocchia M, Crugnola M, Rege-Cambrin G, Martino B, Pierri I, Radaelli F, Specchia G, Pane F, Saglio G, Rosti G, Baccarani M.

Haematologica. 2010 Aug;95(8):1415-9. doi: 10.3324/haematol.2009.021246. Epub 2010 Mar 19.

12.

Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia.

Rosti G, Palandri F, Castagnetti F, Breccia M, Levato L, Gugliotta G, Capucci A, Cedrone M, Fava C, Intermesoli T, Cambrin GR, Stagno F, Tiribelli M, Amabile M, Luatti S, Poerio A, Soverini S, Testoni N, Martinelli G, Alimena G, Pane F, Saglio G, Baccarani M; GIMEMA CML Working Party.

Blood. 2009 Dec 3;114(24):4933-8. doi: 10.1182/blood-2009-07-232595. Epub 2009 Oct 12.

13.

Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure.

Palandri F, Castagnetti F, Soverini S, Poerio A, Gugliotta G, Luatti S, Amabile M, Martinelli G, Rosti G, Baccarani M.

Haematologica. 2009 Dec;94(12):1758-61. doi: 10.3324/haematol.2009.010496. Epub 2009 Jul 16.

14.

Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors.

Soverini S, Gnani A, Colarossi S, Castagnetti F, Abruzzese E, Paolini S, Merante S, Orlandi E, de Matteis S, Gozzini A, Iacobucci I, Palandri F, Gugliotta G, Papayannidis C, Poerio A, Amabile M, Cilloni D, Rosti G, Baccarani M, Martinelli G.

Blood. 2009 Sep 3;114(10):2168-71. doi: 10.1182/blood-2009-01-197186. Epub 2009 Jul 9.

15.

Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response.

Palandri F, Iacobucci I, Soverini S, Castagnetti F, Poerio A, Testoni N, Alimena G, Breccia M, Rege-Cambrin G, Tiribelli M, Varaldo R, Abruzzese E, Martino B, Luciano L, Pane F, Saglio G, Martinelli G, Baccarani M, Rosti G.

Clin Cancer Res. 2009 Feb 1;15(3):1059-63. doi: 10.1158/1078-0432.CCR-08-1195.

16.

Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.

Iacobucci I, Lonetti A, Messa F, Cilloni D, Arruga F, Ottaviani E, Paolini S, Papayannidis C, Piccaluga PP, Giannoulia P, Soverini S, Amabile M, Poerio A, Saglio G, Pane F, Berton G, Baruzzi A, Vitale A, Chiaretti S, Perini G, Foà R, Baccarani M, Martinelli G.

Blood. 2008 Nov 1;112(9):3847-55. doi: 10.1182/blood-2007-09-112631. Epub 2008 Jul 23. Erratum in: Blood. 2010 Sep 23;116(12):2196.

17.

Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome.

Palandri F, Iacobucci I, Castagnetti F, Testoni N, Poerio A, Amabile M, Breccia M, Intermesoli T, Iuliano F, Rege-Cambrin G, Tiribelli M, Miglino M, Pane F, Saglio G, Martinelli G, Rosti G, Baccarani M; GIMEMA Working Party on CML.

Haematologica. 2008 May;93(5):770-4. doi: 10.3324/haematol.12265. Epub 2008 Mar 26.

18.

Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CML.

Palandri F, Iacobucci I, Martinelli G, Amabile M, Poerio A, Testoni N, Soverini S, Castagnetti F, De Vivo A, Breccia M, Specchia G, Abruzzese E, Martino B, Cilloni D, Saglio G, Pane F, Liberati AM, Rosti G, Baccarani M; GIMEMA Working Party on CML.

J Clin Oncol. 2008 Jan 1;26(1):106-11. doi: 10.1200/JCO.2007.13.2373.

PMID:
18165644
19.

Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party.

Rosti G, Iacobucci I, Bassi S, Castagnetti F, Amabile M, Cilloni D, Poerio A, Soverini S, Palandri F, Rege Cambrin G, Iuliano F, Alimena G, Latagliata R, Testoni N, Pane F, Saglio G, Baccarani M, Martinelli G.

Haematologica. 2007 Jan;92(1):101-5.

20.

Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.

Soverini S, Colarossi S, Gnani A, Rosti G, Castagnetti F, Poerio A, Iacobucci I, Amabile M, Abruzzese E, Orlandi E, Radaelli F, Ciccone F, Tiribelli M, di Lorenzo R, Caracciolo C, Izzo B, Pane F, Saglio G, Baccarani M, Martinelli G; GIMEMA Working Party on Chronic Myeloid Leukemia.

Clin Cancer Res. 2006 Dec 15;12(24):7374-9.

21.

Determination of coenzyme Q10 in functional and neoplastic human renal tissues.

Rodriguez-Estrada MT, Poerio A, Mandrioli M, Lercker G, Trinchero A, Tosi MR, Tugnoli V.

Anal Biochem. 2006 Oct 1;357(1):150-2. Epub 2006 Jun 27. No abstract available.

PMID:
16842729
22.

Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.

Iacobucci I, Saglio G, Rosti G, Testoni N, Pane F, Amabile M, Poerio A, Soverini S, Bassi S, Cilloni D, Bassan R, Breccia M, Lauria F, Izzo B, Merante S, Frassoni F, Paolini S, Montefusco E, Baccarani M, Martinelli G; GIMEMA Working Party on Chronic Myeloid Leukemia.

Clin Cancer Res. 2006 May 15;12(10):3037-42.

23.

Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.

Iacobucci I, Rosti G, Amabile M, Poerio A, Soverini S, Cilloni D, Testoni N, Abruzzese E, Montefusco E, Ottaviani E, Iuliano F, Russo D, Gobbi M, Alimena G, Martino B, Terragna C, Pane F, Saglio G, Baccarani M, Martinelli G.

J Clin Oncol. 2006 Jan 20;24(3):454-9.

PMID:
16421422
24.

Skull metastasis in primary vulvar adenocarcinoma of the Bartholin's gland: a case report.

Ferrandina G, Testa AC, Zannoni GF, Poerio A, Scambia G.

Gynecol Oncol. 2005 Aug;98(2):322-4.

PMID:
15936060
25.

ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.

Soverini S, Martinelli G, Rosti G, Bassi S, Amabile M, Poerio A, Giannini B, Trabacchi E, Castagnetti F, Testoni N, Luatti S, de Vivo A, Cilloni D, Izzo B, Fava M, Abruzzese E, Alberti D, Pane F, Saglio G, Baccarani M.

J Clin Oncol. 2005 Jun 20;23(18):4100-9. Epub 2005 May 2.

PMID:
15867198
26.

Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia.

Baccarani M, Martinelli G, Rosti G, Trabacchi E, Testoni N, Bassi S, Amabile M, Soverini S, Castagnetti F, Cilloni D, Izzo B, de Vivo A, Messa E, Bonifazi F, Poerio A, Luatti S, Giugliano E, Alberti D, Fincato G, Russo D, Pane F, Saglio G; GIMEMA Working Party on Chronic Myeloid Leukemia.

Blood. 2004 Dec 15;104(13):4245-51. Epub 2004 Aug 19.

28.

Magnetic resonance spectroscopy and chromatographic methods identify altered lipid composition in human renal neoplasms.

Tosi MR, Rodriguez-Estrada MT, Lercker G, Poerio A, Trinchero A, Reggiani A, Tugnoli V.

Int J Mol Med. 2004 Jul;14(1):93-100.

PMID:
15202022
29.

Fast NMR evaluation of lipids in human tissues.

Tosi MR, Trinchero A, Poerio A, Tugnoli V.

Ital J Biochem. 2003 Dec;52(4):141-4.

PMID:
15141480
30.

Denaturing-HPLC-based assay for detection of ABL mutations in chronic myeloid leukemia patients resistant to Imatinib.

Soverini S, Martinelli G, Amabile M, Poerio A, Bianchini M, Rosti G, Pane F, Saglio G, Baccarani M; Italian Cooerative Study Group on Chronic Myeloid Leukemia; European LeukemiaNet-6th Framework Program of the European Community.

Clin Chem. 2004 Jul;50(7):1205-13. Epub 2004 Apr 23.

31.
32.

Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery.

Ferrandina G, Ranelletti FO, Legge F, Lauriola L, Poerio A, Zannoni GF, Smaniotto D, Margariti PA, Macchia G, Scambia G.

Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):21-7.

PMID:
12504032
33.

Gynecological malignancies in elderly patients: is age 70 a limit to standard-dose chemotherapy? An Italian retrospective toxicity multicentric study.

Ceccaroni M, D'Agostino G, Ferrandina G, Gadducci A, Di Vagno G, Pignata S, Poerio A, Salerno MG, Fanucchi A, Lapresa MT, Tambaro R, Scambia G.

Gynecol Oncol. 2002 Jun;85(3):445-50.

PMID:
12051872
34.

Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin.

D'Agostino G, Distefano M, Greggi S, Salerno M, Ferrandina G, Poerio A, Mancuso S, Scambia G.

Cancer Chemother Pharmacol. 2002 Mar;49(3):256-60. Epub 2002 Jan 16.

PMID:
11935219
35.

Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients.

Giannice R, Susini T, Ferrandina G, Poerio A, Margariti PA, Carminati R, Marana E, Mancuso S, Scambia G.

Cancer. 2001 Nov 15;92(10):2562-8.

PMID:
11745190
36.

[Magnetic fields in physical therapy. Experience in orthopedics and traumatology rehabilitation].

Borg MJ, Marcuccio F, Poerio AM, Vangone A.

Minerva Med. 1996 Oct;87(10):495-7. Italian.

PMID:
8992414

Supplemental Content

Loading ...
Support Center